Publication | Closed Access

An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia

VaccinationVector-borne PathogenDose StudyPhase 1Vector ControlAntibody ScreeningDengue Monoclonal AntibodyArbovirusEpidemiologyVector Borne Disease